These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20626325)

  • 1. Preventing cisplatin induced ototoxicity by N-acetylcysteine and salicylate.
    Yıldırım M; Inançlı HM; Samancı B; Oktay MF; Enöz M; Topçu I
    Kulak Burun Bogaz Ihtis Derg; 2010; 20(4):173-83. PubMed ID: 20626325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy.
    Riga MG; Chelis L; Kakolyris S; Papadopoulos S; Stathakidou S; Chamalidou E; Xenidis N; Amarantidis K; Dimopoulos P; Danielides V
    Am J Clin Oncol; 2013 Feb; 36(1):1-6. PubMed ID: 22134515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model.
    Thomas Dickey D; Muldoon LL; Kraemer DF; Neuwelt EA
    Hear Res; 2004 Jul; 193(1-2):25-30. PubMed ID: 15219317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically accurate assessment and grading of ototoxicity.
    Chang KW
    Laryngoscope; 2011 Dec; 121(12):2649-57. PubMed ID: 22109766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cisplatin ototoxicity. A clinical study].
    Schröder M; Laskawi R; Stennert E; Kühnle H; Thiele FW
    Laryngol Rhinol Otol (Stuttg); 1986 Feb; 65(2):86-9. PubMed ID: 3959692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of high-tone audiometry in monitoring for ototoxicity.
    Tange RA; Dreschler WA; van der Hulst RJ
    Arch Otorhinolaryngol; 1985; 242(1):77-81. PubMed ID: 3899068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The ototoxicity of cisplatin: a clinical study].
    Vantrappen G; Rector E; Debruyne F
    Acta Otorhinolaryngol Belg; 1990; 44(4):415-21. PubMed ID: 2093285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of noise- and drug-induced hearing loss with D-methionine.
    Campbell KC; Meech RP; Klemens JJ; Gerberi MT; Dyrstad SS; Larsen DL; Mitchell DL; El-Azizi M; Verhulst SJ; Hughes LF
    Hear Res; 2007 Apr; 226(1-2):92-103. PubMed ID: 17224251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients.
    Yoo J; Hamilton SJ; Angel D; Fung K; Franklin J; Parnes LS; Lewis D; Venkatesan V; Winquist E
    Laryngoscope; 2014 Mar; 124(3):E87-94. PubMed ID: 23946126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical study of cisplatin ototoxicity].
    Frade González C; Gómez González JL; Pescador Mesonero C; Criado Martín D; Muñoz Herrera A
    Acta Otorrinolaringol Esp; 1990; 41(1):11-4. PubMed ID: 2337477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
    Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
    Laryngoscope; 2004 Sep; 114(9):1660-7. PubMed ID: 15475801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are intratympanic injections of N-acetylcysteine and methylprednisolone protective against Cisplatin-induced ototoxicity?
    Saliba I; El Fata F; Ouelette V; Robitaille Y
    J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):236-43. PubMed ID: 20470667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
    Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
    Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
    Dhooge I; Dhooge C; Geukens S; De Clerck B; De Vel E; Vinck BM
    Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing.
    Kopelman J; Budnick AS; Sessions RB; Kramer MB; Wong GY
    Laryngoscope; 1988 Aug; 98(8 Pt 1):858-64. PubMed ID: 3398663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Follow-up studies and prognostic references for pre- and post-therapy pure tone audiometry and acoustically evoked potentials in sudden deafness].
    Welkoborsky HJ; Wissen-Siegert I; Maurer J; Bernal-Sprekelsen M
    Laryngorhinootologie; 1991 Jan; 70(1):5-9. PubMed ID: 2025349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity.
    Nader ME; Théorêt Y; Saliba I
    Laryngoscope; 2010 Jun; 120(6):1208-13. PubMed ID: 20513041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosing study on the effectiveness of salicylate/N-acetylcysteine for prevention of noise-induced hearing loss.
    Coleman J; Huang X; Liu J; Kopke R; Jackson R
    Noise Health; 2010; 12(48):159-65. PubMed ID: 20603572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.
    Schmidt CM; Knief A; Lagosch AK; Deuster D; am Zehnhoff-Dinnesen A
    Ear Hear; 2008 Dec; 29(6):830-7. PubMed ID: 18772725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.